Thus, ACKR2 appears as a novel immunomodulatory actor in the setting of diet-induced inflammation of the hypothalamus, and approaches aimed at raising ACKR2 hypothalamic expression may be practical for enhancing metabolic control in obesity (124). The gene discussed is ACKR2; the disease is obesity due to melanocortin 4 receptor deficiency.